App-Quantinova.ai

High Serum Levels of Thrombospondin-2 Correlate with Poor Prognosis of Patients with Heart Failure with Preserved Ejection Fraction

Yasuhiro Izumiya - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with preserved ejection fraction

N/A

Ablation of the Hypertension Candidate Gene ATP2B1 Results in Increased Blood Pressure and Cardiac Hypertrophic Remodeling

Min Zi - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

Angiotensin II

Cardiac Troponin T, Natriuretic Peptide, and Long-term Risk of Acute Kidney Injury in the Community: The Atherosclerosis Risk in Communities Study

Kunihiro Matsushita - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Chronic kidney disease

N/A

Elevated Plasma levels of Neutral Endpeptidase in Hypertension Patients Treated with Angiotensin Converting Enzyme Inhibitors

Seigo Sugiyama - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Angiotensin II

Sirt2 Regulates Cardiac Hypertrophic in Response to Pressure Overload

Rongxue Wu - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Growth Differentiation Factor-15 Independently Predicts 2 Year Mortality in Patients With Acute Coronary Syndrome: Observations From the A to Z Trial

James A de Lemos - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute Coronary Syndromes

N/A

The Predictive Value of NT-pro BNP in Cardiac Arrest Patients Treated with Mild Hypothermia

Jeong Ho Park - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

High NT-proBNP in Cardiopulmonary Resuscitated Patients Treated With Mild Therapeutic Hypothermia is Associated With Mortality

Bob Smit - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Diagnostic and Prognostic Value of the B-Type Natriuretic Peptide in Elderly Patients with Suspected Heart Failure in the Emergency Room

Eduardo Pitthan - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with preserved ejection fraction

N/A

Brain Natriuretic Peptide Levels Predict Stroke Outcomes in the Acute Rehabilitation Setting

Mery Elashvili - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

The Role of B-type Natriuretic Peptide as a Prognostic Factor for Endocarditis at the Emergency Room

Priscila Goldstein - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Infective endocarditis

N/A

Determinant Factors of Elevated Plasma B-type Natriuretic Peptide Level in Severe Aortic Stenosis

Takayuki Kawata - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular diastolic dysfunction

N/A

First-Year Brain Natriuretic Peptide as a Biomarker after Heart Transplant Predicts Outcome and Severity of Cardiac Allograft Vasculopathy

Jignesh Patel - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cardiac allograft vasculopathy

N/A

Adaptive Servo-ventilation Therapy Improves Long-term Prognosis in Heart Failure Patients With Anemia and Sleep-disordered Breathing

Akiomi Yoshihisa - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Sleep apnoea

N/A

Brain Natriuretic Peptide as a Predictor of Outcome for Non-traumatic Subarachnoid Hemorrhage

Ikuo Sato - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Subarachnoid hemorrhage

Norepinephrine bitartrate

Plasma Carnitine Level in Heart Failure Patients With Sleep Disordered Breathing

Akiomi Yoshihisa - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

Carnitine

Relation Between Natriuretic Peptide and Pulmonary Capillary Wedge Pressure Estimated by the Combination of Left Atrial Volume and Function With Speckle Tracking Echocardiography

Masanori Kawasaki - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Mitral stenosis

N/A

Overnight Beneficial Impacts of Adaptive Servo Ventilation on Cardiac Overload, Sympathetic Nervous Activity, and Myocardial Damage in Chronic Heart Failure Patients With Cheyne-stokes Respiration

Akiomi Yoshihsa - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Excess Circulating B-Type Natriuretic Peptide (BNP): A Previously Unsuspected Cause of Severe Orthostatic Hypotension

Margarita Patarroyo Aponte - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Orthostatic hypotension

N/A

Relationship Between Natriuretic Peptide and Pulmonary Capillary Wedge Pressure Estimated by Three-Dimensional Speckle Tracking Echocardiography in Patients With Dialysis

Michael R Zile - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Filters

387 Abstracts